From Policy to Patients:
A Legacy of Care
Since its founding in 1999, the Indian Pharmaceutical Alliance (IPA) has been at forefront of India’s transformation into a global pharmaceutical leader — bridging policy and patient care through advocacy, innovation, and an unwavering commitment to quality and access. Representing 23 of the country’s top research-based pharmaceutical companies, IPA continues to play a catalyst in shaping national and global pharmaceutical policy with one guiding principle: putting patients first.
Our Mission
Innovation
that transforms healthcare
Driving an innovation-led research ecosystem to position India as a global leader in life sciences with interdisciplinary collaboration, scientific breakthroughs, and policies that enable long-term, sustainable innovation.
Inside the Lab
Quality
that builds trust
Commitment to drive excellence in pharmaceutical quality by building capabilities, benchmarking against global standards, and promoting the sharing of best practices across the industry.
Our Quality Standards
Global Reach
that expands access
Expanding global footprint of Indian companies to enhance the affordability, availability, and accessibility of quality medicines worldwide.
Track the ImpactInsights
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India’s pharmaceutical sector has become the world’s largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
Blog 12 May 2025 • 5 min read
India’s Green Manufacturing Odyssey: A New Era for Pharma
Indian pharma isn’t just advancing health — it’s reimagining responsibility. From green manufacturing practices to sustainable sourcing and energy efficiency, IPA members are embedding environmental stewardship into....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
External Studies May 6, 2024
US–India Medicine Partnership: India’s Contribution to the US Healthcare System
View Report ›
External Studies November 17, 2021
Roadmap for Pharma R&D: Developing an Innovation Index as a Monitoring and Evaluation Metric
View Report ›
External Studies October 1, 2021
ET SMART pharma summit in collaboration with knowledge partner: Indian Pharmaceutical Alliance Conference report
View Report ›
Blog May 19, 2025 • 4 min read
Space: Pharma’s Next Frontier?
Space, once the exclusive domain of astronauts, space stations, and satellites, is emerging as a critical enabler of pharmaceutical and biomedical innovation.
Read More ›
Blog July 13, 2024 • 4 min read
To Improve Quality, Build a Strong Culture: Dilip Shanghvi
Read More ›
Publication February 1, 2025
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
View Publication ›
Spotlight
The Pharma Academy for Global Excellence
To meet the evolving needs of a globally competitive pharmaceutical industry, the Indian Pharmaceutical Alliance (IPA), in collaboration with 13 leading member companies, has launched the Pharmaceutical Academy for Global Excellence (P.A.G.E.) — India’s first industry-led skilling initiative focused on Manufacturing and Quality Excellence.
P.A.G.E. reflects the collective vision of the industry to strengthen the talent pipeline by equipping early-career professionals with practical, high-impact training aligned to global quality and regulatory standards.
Designed by industry experts, the program offers hands-on exposure in critical areas such as Good Manufacturing Practices (GMP), Oral Solid Dosage (OSD) manufacturing, High Performance Liquid Chromatography (HPLC), and microbiology.
Learn MorePharmacy of the World
Explore Data Centre#1
Global leader in generic medicines
3rd
Largest pharma industry in the world by volume
5th
Largest net exporter of medicines in the world
$58B
Annual output of the Indian pharmaceutical industry
750+
FDA-compliant sites – highest outside the US
11th
Largest pharma industry in the world by value
2x
Export orientation compared to overall manufacturing sector
$30B
Value of Indian pharmaceutical exports in FY25
25 Years of Policy, Partnership, and Progress
IPA is formed by leading Indian pharma companies to provide a unified voice for the industry.
1999
IPA helps shape India’s TRIPS position at the WTO, safeguarding public health priorities.
2003
IPA leads engagement on India’s patent law amendments during the shift to a product patent regime.
2005
IPA gains global recognition in policy and regulatory forums on IP, generics, and pricing.
2010
Hosts the first Global Pharmaceutical Quality Summit (GPQS), uniting industry and regulators to advance quality standards and global best practices
2015
Partners with government on Make in India, API self-reliance, and affordability strategies.
2019
Plays a central role during COVID-19 — enabling vaccine access, ensuring medicine supply, and supporting emergency policy response.
2020
Hosts the first Global Innovation Summit with 3000+ attendees, outlining key imperatives to strengthen India’s life sciences innovation ecosystem.
2021
IPA members lead global biosimilar exports, marking India's innovation-driven growth.
2024
IPA marks 25 years — championing policy, access, innovation, and global healthcare leadership.